Abacavir Sulfate | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Abacavir Sulfate
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Abacavir Sulfate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

32 API Suppliers, 12 USDMF, 10 CEP/COS, 1 JDMF, 11 EU WC, 3 KDMF, 16 NDC API, 17 Listed Suppliers, $ API Reference Price

32 API Suppliers
12 USDMF
10 CEP/COS
1 JDMF
11 EU WC
3 KDMF
16 NDC API
17 Listed Suppliers
$ API Reference Price

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

66 FDF Dossiers, 35 FDA Orange Book, 8 Europe, 11 Canada, 9 South Africa, 3 Listed Dossiers

66 FDF Dossiers
35 FDA Orange Book
8 Europe
11 Canada
9 South Africa
3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 600MG BASE;EQ 50MG BASE;300MG, TABLET;ORAL - EQ 300MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;ORAL - EQ 20MG BASE/ML, TABLET;ORAL - EQ 600MG BASE;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 600MG BASE;EQ 50MG BASE;300MG
TABLET;ORAL - EQ 300MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;ORAL - EQ 20MG BASE/ML
TABLET;ORAL - EQ 600MG BASE;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 18 SPI Pharma, 2 Seqens, 5 DKSH, 5 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 8 Actylis, 1 Aeon Procare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 22 BASF, 1 Clariant, 10 Corel Pharma Chem, 4 DFE Pharma, 2 Finar, 11 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 19 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 5 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 29 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

60 Fillers, Diluents & Binders, 53 Coating Systems & Additives, 32 Disintegrants & Superdisintegrants, 32 Controlled & Modified Release, 27 Direct Compression, 24 Solubilizers, 23 Thickeners and Stabilizers, 21 Film Formers & Plasticizers, 21 Taste Masking, 20 Granulation, 18 Parenteral, 17 Chewable & Orodispersible Aids, 15 Topical, 14 Co-Processed Excipients, 13 Lubricants & Glidants, 8 Emulsifying Agents, 6 API Stability Enhancers, 5 Empty Capsules, 5 Coloring Agents, 5 Rheology Modifiers, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents, 1 Soft Gelatin

60 Fillers, Diluents & Binders
53 Coating Systems & Additives
32 Disintegrants & Superdisintegrants
32 Controlled & Modified Release
27 Direct Compression
24 Solubilizers
23 Thickeners and Stabilizers
21 Film Formers & Plasticizers
21 Taste Masking
20 Granulation
18 Parenteral
17 Chewable & Orodispersible Aids
15 Topical
14 Co-Processed Excipients
13 Lubricants & Glidants
8 Emulsifying Agents
6 API Stability Enhancers
5 Empty Capsules
5 Coloring Agents
5 Rheology Modifiers
4 Vegetarian Capsules
3 Surfactant & Foaming Agents
1 Soft Gelatin

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 23 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
23 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 8 Finished Drug Prices, 5 Annual Reports

3 US Medicaid Prescriptions
8 Finished Drug Prices
5 Annual Reports

MARKET PLACE

1 APIs, 2 FDF Dossiers

1 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 US Patents, 4 US Exclusivities, 8 Health Canada Patents

8 US Patents
4 US Exclusivities
8 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 2 Others

3 EDQM
2 USP
2 Others

$ API Ref.Price (USD/KG) : 345 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

8 All

01 8GlaxoSmithKline Inc.

filter Patent Reset all filters

8 All

01 21340589

02 22033044

03 22216634

04 22289753

filter Product Reset all filters

8 All

01 8Abacavir Sulfate

filter Dosage Reset all filters

8 All

01 4Oral Solution

02 4Tablet

filter Exp Date Reset all filters

8 All

01 22010-12-21

02 22016-03-28

03 22016-06-08

04 22018-05-14

Product Main Page

01

GlaxoSmithKline Inc.

Abacavir Sulfate

BioAsia

Not Confirmed

GlaxoSmithKline Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-03-28

Date Granted : 2004-07-20

Abacavir Sulfate

Brand Name : ZIAGEN

Patent Number : 2216634

Filing Date : 1996-03-28

Strength per Unit : 300 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-03-28

Date Granted : 2004-07-20

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

GlaxoSmithKline Inc.

Abacavir Sulfate

BioAsia

Not Confirmed

GlaxoSmithKline Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-03-28

Date Granted : 2004-07-20

Abacavir Sulfate

Brand Name : ZIAGEN

Patent Number : 2216634

Filing Date : 1996-03-28

Strength per Unit : 20 mg / ml

Dosage Form : Oral Solution

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-03-28

Date Granted : 2004-07-20

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

GlaxoSmithKline Inc.

Abacavir Sulfate

BioAsia

Not Confirmed

GlaxoSmithKline Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-05-14

Date Granted : 2007-01-23

Abacavir Sulfate

Brand Name : ZIAGEN

Patent Number : 2289753

Filing Date : 1998-05-14

Strength per Unit : 300 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-05-14

Date Granted : 2007-01-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

GlaxoSmithKline Inc.

Abacavir Sulfate

BioAsia

Not Confirmed

GlaxoSmithKline Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-06-08

Date Granted : 1999-06-08

Abacavir Sulfate

Brand Name : ZIAGEN

Patent Number : 1340589

Filing Date : 1989-06-23

Strength per Unit : 300 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-06-08

Date Granted : 1999-06-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

GlaxoSmithKline Inc.

Abacavir Sulfate

BioAsia

Not Confirmed

GlaxoSmithKline Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2010-12-21

Date Granted : 1999-07-13

Abacavir Sulfate

Brand Name : ZIAGEN

Patent Number : 2033044

Filing Date : 1990-12-21

Strength per Unit : 300 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2010-12-21

Date Granted : 1999-07-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

GlaxoSmithKline Inc.

Abacavir Sulfate

BioAsia

Not Confirmed

GlaxoSmithKline Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-05-14

Date Granted : 2007-01-23

Abacavir Sulfate

Brand Name : ZIAGEN

Patent Number : 2289753

Filing Date : 1998-05-14

Strength per Unit : 20 mg / ml

Dosage Form : Oral Solution

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-05-14

Date Granted : 2007-01-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

GlaxoSmithKline Inc.

Abacavir Sulfate

BioAsia

Not Confirmed

GlaxoSmithKline Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-06-08

Date Granted : 1999-06-08

Abacavir Sulfate

Brand Name : ZIAGEN

Patent Number : 1340589

Filing Date : 1989-06-23

Strength per Unit : 20 mg / ml

Dosage Form : Oral Solution

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-06-08

Date Granted : 1999-06-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

GlaxoSmithKline Inc.

Abacavir Sulfate

BioAsia

Not Confirmed

GlaxoSmithKline Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2010-12-21

Date Granted : 1999-07-13

Abacavir Sulfate

Brand Name : ZIAGEN

Patent Number : 2033044

Filing Date : 1990-12-21

Strength per Unit : 20 mg / ml

Dosage Form : Oral Solution

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2010-12-21

Date Granted : 1999-07-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!